TM Owner Teva Pharmaceuticals
Tamoxifen 20mg Tablet
Global Shipping : Reliable Global Distribution Network
Express Delivery : Priority Shipping for Every Order
Secure Payments : Trusted Payment Protection System
Secure Handling
24/7 Worldwide Support
Global Access
Worldwide Access to Health
Cold-Chain Expert
Excellence in Cold-Chain
Trusted Supply
Certified Medical Supply
Indications & Clinical Uses
- This product is labelled simply as 'Tamoxifen', a generic/molecule name rather than a distinct trade name; the originator brand, Nolvadex, is no longer the current US market product.
- This 20 mg tablet corresponds to Teva Pharmaceuticals' Tamoxifen Citrate Tablets, USP.
- Tamoxifen is a selective oestrogen-receptor modulator (SERM) and is unrelated to oseltamivir (Tamiflu), an antiviral for influenza — the two names sound similar but treat completely different conditions and must never be confused.
- Tamoxifen 20 mg tablets are approved for treatment of metastatic breast cancer in women and men, adjuvant treatment of node-positive and node-negative breast cancer after surgery, treatment of ductal carcinoma in situ (DCIS) following breast-conserving surgery and radiation, and reduction of breast cancer risk in women aged 35 years and older who are at high risk based on validated risk models.
- It is taken by mouth once or twice daily as directed and is prescribed and monitored by a healthcare provider experienced in breast cancer treatment or risk management.
Side Effects
- Common side effects of Tamoxifen include hot flashes, vaginal discharge or bleeding, irregular menstrual periods, nausea, fluid retention and mild weight changes; these affect a substantial proportion of patients and are usually manageable.
- Tamoxifen carries a boxed warning for serious and sometimes fatal events: uterine malignancies (endometrial cancer and uterine sarcoma), stroke, and pulmonary embolism (a blood clot in the lung) have all occurred more often in women taking tamoxifen than in those who did not, particularly in the risk-reduction (prevention) setting.
- Report any unusual vaginal bleeding, pelvic pain, sudden leg swelling or pain, chest pain, sudden breathlessness, slurred speech or one-sided weakness immediately, as these can signal a uterine tumour, blood clot or stroke.
- Also report visual changes, since rare cataracts and other eye problems have been described with long-term use.
Precautions & Warnings
- Before starting Tamoxifen, discuss your personal and family history of blood clots, stroke, or uterine disease, since these raise the risk of the serious events described in the boxed warning.
- Tamoxifen must not be used during pregnancy — it can cause fetal harm — and women who can become pregnant must use effective non-hormonal contraception during treatment and for about 2 months after stopping; do not breastfeed while taking it.
- Tamoxifen should not be combined with coumarin-type anticoagulants such as warfarin.
- Liver function should be monitored periodically, and women should have regular gynaecological check-ups to screen for endometrial changes.
- Tamoxifen is an oral tablet only, taken by mouth; it is not given by injection.
- Tell your healthcare provider about any history of deep vein thrombosis or pulmonary embolism, which are contraindications to starting tamoxifen.
Avoid Interactions
- Tamoxifen increases the anticoagulant effect of warfarin and similar coumarin-type blood thinners, raising bleeding risk, so it should not be combined with them and INR must be monitored closely if unavoidable.
- Rifampin and other strong enzyme inducers can lower tamoxifen levels and reduce its effectiveness.
- Some antidepressants that strongly inhibit the CYP2D6 enzyme, such as paroxetine and fluoxetine, can reduce the conversion of tamoxifen to its active form and are best avoided if an alternative antidepressant is needed; your healthcare provider can advise on safer options.
- Tamoxifen should not be combined with the aromatase inhibitor anastrozole.
- Tell your healthcare provider and pharmacist about every prescription and over-the-counter medicine, herbal product and supplement you take, since several common drugs can interact with tamoxifen's metabolism or bleeding risk.
References
Frequently Asked Questions
Tamoxifen citrate treats metastatic breast cancer, is used after surgery for node-positive or node-negative breast cancer, treats ductal carcinoma in situ, and reduces breast cancer risk in high-risk women 35 and older. It is not related to Tamiflu, an antiviral flu medicine with a similar-sounding name.
Tamoxifen tablets are taken by mouth, once or twice daily as prescribed, with or without food, at the same times each day. Treatment often continues for 5 to 10 years in breast cancer, so take it exactly as directed for as long as your doctor recommends.
Hot flashes, vaginal discharge, irregular periods and nausea are common. Tamoxifen also has a boxed warning for uterine cancer, stroke and blood clots in the lung. Get urgent help for unusual vaginal bleeding, leg swelling, chest pain, sudden breathlessness or one-sided weakness.
Avoid warfarin and similar blood thinners, since tamoxifen increases their effect and bleeding risk. Avoid the antidepressants paroxetine and fluoxetine where possible, as they can reduce tamoxifen's effectiveness. Effective non-hormonal contraception is required, since tamoxifen can harm an unborn baby.
Your healthcare provider will check liver function periodically and arrange regular gynaecological review to screen for uterine changes, since tamoxifen raises the risk of endometrial cancer. Report any unusual vaginal bleeding or pelvic pain promptly between scheduled visits.
No. Tamoxifen can harm an unborn baby, so effective non-hormonal contraception is required during treatment and for about 2 months after stopping, and breastfeeding should be avoided. Discuss any history of blood clots or stroke with your doctor before starting, since these raise serious risks.

Trusted & Reliable – Your Partner in Global Distribution.
We provide comprehensive lines of pharmaceutical products to support all your healthcare distribution needs.